Ambalal Sarabhai Enterprises Limited (BOM:500009)
India · Delayed Price · Currency is INR 40.55
-0.58 (-1.41%)
At close: Sep 25, 2026
BOM:500009 Market Cap
BOM:500009 has a market cap or net worth of 3.11 billion as of September 25, 2026. Its market cap has increased by 26.80% in one year.
Market Cap
3.11B
Enterprise Value
3.51B
Revenue
2.06B
Ranking
n/a
PE Ratio
22.94
Stock Price
40.55
ChartMarket Cap Chart
Since May 31, 1999, BOM:500009's market cap has increased from 431.71M to 3.11B, an increase of 619.81%. That is a compound annual growth rate of 7.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 3.11B | 41.88% |
| Dec 31, 2025 | 2.19B | -46.66% |
| Dec 31, 2024 | 4.11B | 40.93% |
| Dec 29, 2023 | 2.91B | 41.34% |
| Dec 30, 2022 | 2.06B | -20.06% |
| Dec 31, 2021 | 2.58B | 66.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medicamen Biotech | 4.33B |
| Jenburkt Pharmaceuticals | 4.19B |
| Astonea Labs | 3.55B |
| Sat Kartar Life | 2.96B |
| BDH Industries | 2.82B |
| Bilcare | 2.57B |
| Gennex Laboratories | 2.45B |
| Accretion Pharmaceuticals | 2.26B |